Authorized dosing is formulation-specific and not determined by sex. IGF-1, glucose control, cancer history and pituitary status require clinical review.
Prescription ingredient
Endocrine & body composition
Tesamorelin
A prescription ingredient authorized in specific formulations for excess abdominal fat in adults with HIV-associated lipodystrophy—not general weight loss.
Tesamorelin10 mg
Add a Featured Image in WordPress to replace this product placeholder.
ClassificationGrowth-hormone-releasing factor analogue
Catalogue strength10 mg
Current contextPrescription ingredient
What it is
A prescription ingredient authorized in specific formulations for excess abdominal fat in adults with HIV-associated lipodystrophy—not general weight loss.
Its catalogue classification is growth-hormone-releasing factor analogue. Status and formulation matter: a research-labelled vial is not automatically equivalent to an authorized prescription medicine containing a similarly named ingredient.
What it is studied or used for
- HIV-associated lipodystrophy
- Growth-hormone and IGF-1 signalling
- Visceral adipose-tissue outcomes
A research topic is not proof of a health benefit. Evidence can range from cell and animal models to controlled human trials, and those levels should not be treated as equivalent.
How it is used or administered
Authorized route and schedule depend on the exact prescription product, indication and patient. Use only when prescribed and dispensed by qualified professionals.
Dosing context for men and women
Authorized dosing is formulation-specific and not determined by sex. Pregnancy is a major contraindication because reducing visceral tissue is not appropriate during pregnancy.
Why no universal number? Dose depends on the exact formulation, legal status, indication, concentration, patient factors and monitoring. Publishing a single male or female number would be misleading and unsafe.
Active shelf life and storage
Follow the printed expiry and the dispensing label. Shelf life cannot be transferred between brands, concentrations, compounded products or reconstituted preparations.
Follow the manufacturer and pharmacy label for the exact dispensed formulation. Temperature limits can differ between tablets, creams and injectable products.
What it may be paired with
Combining with growth hormone, CJC analogues or secretagogues can increase endocrine exposure and should not occur outside specialist care.
Safety boundary
The presence of an approved active ingredient does not establish that every formulation or seller is authorized.
Continue with primary sources
Evidence and regulatory status change. Verify the exact active ingredient, formulation and jurisdiction before drawing conclusions.
Product availability
View Tesamorelin on the main site ↗
Ready to leave the education library?
Purchasing, pricing, shipping and product-specific lot information are handled on the main Cryos Bio Labs website.